Sante Ventures
Santé Ventures is a healthcare and life science venture capital firm that invests exclusively in early-stage companies developing new medical technologies or healthcare delivery models.[1] The firm, which is based in Austin, Texas, was founded in 2006 and has $281 million in capital under management.
Team
- Kevin Lalande, Managing Director
- Joe Cunningham, MD, Managing Director
- Doug French, Managing Director
- Casey Cunningham, MD, Chief Scientific Officer
- Louis Bock, Venture Partner
- James Eadie, MD, Principal
- Bill Paape, Chief Financial Officer
- Derek Mazur, Senior Analyst
- Julie Rhee, Director of Marketing and Investor Relations[2]
References
- Santé invests in Austin biomedical startup TVA Medical. Austin American-Statesman, January 10, 2010
- Austin-based Biotech Startup Gets $5 million. Austin American-Statesman, November 30, 2009
- Terapio Collects $5M from Sante. Austin Business Journal, November 30, 2009
- New Texas Cancer Institute Plans High-Impact Research. Fort Worth Business Press, August 31, 2009
- Sante Sees Real Opportunity in Austin Companys Future. Austin American-Statesman, June 2, 2009
- Up the Ladder. Austin American-Statesman, May 20, 2009
- Biotech Company Raises 2.5 Million. Austin American-Statesman, April 10, 2009
External links
- Santé Ventures (company website)
|
This article is issued from Wikipedia - version of the Wednesday, January 27, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.